-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Initiates Coverage On Design Therapeutics with Buy Rating, Announces Price Target of $15

Benzinga·03/16/2026 13:16:49
Listen to the news
Jefferies analyst Faisal Khurshid initiates coverage on Design Therapeutics (NASDAQ:DSGN) with a Buy rating and announces Price Target of $15.